Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve (IST:ANGEN) Debt-to-Equity : 0.02 (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve Debt-to-Equity?

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was ₺2.7 Mil. Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was ₺14.5 Mil. Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Total Stockholders Equity for the quarter that ended in Sep. 2023 was ₺813.4 Mil. Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's debt to equity for the quarter that ended in Sep. 2023 was 0.02.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Debt-to-Equity or its related term are showing as below:

IST:ANGEN' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.02 Max: 0.94
Current: 0.02

During the past 5 years, the highest Debt-to-Equity Ratio of Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve was 0.94. The lowest was 0.01. And the median was 0.02.

IST:ANGEN's Debt-to-Equity is ranked better than
91.53% of 708 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs IST:ANGEN: 0.02

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve Debt-to-Equity Historical Data

The historical data trend for Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve Debt-to-Equity Chart

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-Equity

0.94

0.82

0.10

0.01

0.02

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve Quarterly Data
	Dec18	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Debt-to-Equity	Get a 7-Day Free Trial										0.01	0.02	0.02	0.02	0.02

Competitive Comparison of Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Debt-to-Equity

For the Medical Devices subindustry, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Debt-to-Equity falls into.

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.319	+	11.005)	/	816.401
	=	0.02

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Debt to Equity Ratio for the quarter that ended in Sep. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.665	+	14.467)	/	813.443
	=	0.02

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve (IST:ANGEN) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve (IST:ANGEN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi Ve (IST:ANGEN) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Egitim Mah. Kasap Ismail, Sk. No:10 D:23, Kadikoy, Istanbul, TUR, 34722

Website

https://www.anatoliageneworks.com

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi Ve Ticaret AS is an international biotechnology company. It is engaged in designing, developing, and manufacturing Real-Time PCR kits, nucleic acid extraction kits, and automated nucleic acid extraction instruments. It also manufactures NA Extraction kits, Microbiology kits, Genetic Disorders kits, Panel kits, Sequencing kits, Food Testing kits.

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve (IST:ANGEN) Headlines

No Headlines